Emblem
Fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives.
Employees
Market cap
$5.9m
Enterprise valuation
$40m (Public information from Oct 2023)
Share price
CAD0.02 AH.TO
Toronto Ontario (HQ)
Financials
Estimates*
| CAD | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.3m | 16.4m | 44.5m | 43.1m | 42.8m | 74.2m | 85.1m |
| % growth | 20976 % | 391 % | 172 % | - | (1 %) | 73 % | 15 % |
| EBITDA | (17.9m) | (17.4m) | 164m | (150m) | (11.0m) | - | - |
| % EBITDA margin | (537 %) | (106 %) | 368 % | (348 %) | (26 %) | - | - |
| Profit | (18.5m) | (39.6m) | (247m) | (170m) | (34.6m) | - | - |
| % profit margin | (557 %) | (242 %) | (555 %) | (394 %) | (81 %) | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | N/A | IPO | |
| N/A | $43.3m | Post IPO Equity | |
* | $40.3m | Post IPO Debt | |
* | N/A | $13.0m | Post IPO Equity |
* | $22.7m | Post IPO Equity | |
| Total Funding | - | ||
Related Content
Recent News about Emblem
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
